News & Updates

PAP-treated sleep apnoea tied to reduced COVID-19 risk

14 Jun 2021 by

Individuals with obstructive sleep apnoea (OSA) may have an increased risk of COVID-19, with the risk reducing with adherence to positive airway pressure (PAP) therapy, according to a study presented at ATS 2021.

PAP-treated sleep apnoea tied to reduced COVID-19 risk

14 Jun 2021

Regional variations in prevalence, hidden reservoir sustain malaria in Myanmar

14 Jun 2021

Though the overall disease prevalence is low, transmission of malaria varies widely across villages in Myanmar, a recent study has found. Compounding this heterogeneity is a large hidden reservoir of asymptomatic Plasmodium vivax infections, which further complicates disease elimination.

Regional variations in prevalence, hidden reservoir sustain malaria in Myanmar

14 Jun 2021

Therapeutic rivaroxaban for stable COVID-19: More risk than benefit

13 Jun 2021 by

In hospitalized COVID-19 patients with elevated D-dimer levels who were under stable condition, initial in-hospital anticoagulation using a therapeutic dose of rivaroxaban 20 mg did not improve clinical outcomes compared with standard prophylactic anticoagulation, according to the ACTION* trial presented at ACC.21 Meeting.

Therapeutic rivaroxaban for stable COVID-19: More risk than benefit

13 Jun 2021

Antibody cocktail cuts hospitalization, death in COVID-19

12 Jun 2021 by

The REGN-COV2 monoclonal antibody cocktail comprising casirivimab and imdevimab significantly reduces the risk of hospitalization and all-cause death by 71 percent compared with placebo in nonhospitalized patients with COVID-19, according to a large phase III study presented at the ATS 2021 Meeting.

Antibody cocktail cuts hospitalization, death in COVID-19

12 Jun 2021

Skin reactions after Moderna, Pfizer COVID-19 vaccination not a cause for alarm

11 Jun 2021 by

A spectrum of cutaneous reactions has been observed following Moderna and Pfizer vaccinations against COVID-19, reveals a study. Such dermatologic reactions mimic SARS-CoV-2 infection itself, such as pernio or chilblains. However, most patients with first-dose reactions show no second-dose reaction, and no serious adverse events have been reported after the first or second dose.

Skin reactions after Moderna, Pfizer COVID-19 vaccination not a cause for alarm

11 Jun 2021

Chronic liver disease not a comorbidity of COVID-19

10 Jun 2021

Chronic liver disease does not seem to be a strong comorbid condition of the novel coronavirus disease (COVID-19), a recent study has found.

Chronic liver disease not a comorbidity of COVID-19

10 Jun 2021

Wearing masks does not prevent COVID-19 infection

10 Jun 2021 by

Wearing surgical masks in addition to other public health measures is not associated with a significant reduction in SARS-CoV-2 infection rate among wearers in a community with modest infection rates, some degree of social distancing, and uncommon general mask use, according to a Danish study.

Wearing masks does not prevent COVID-19 infection

10 Jun 2021

What makes dentists prescribe antibiotics inappropriately?

09 Jun 2021

General dental practitioners who are less trained and less confident in administering local anaesthesia are more likely to inappropriately prescribe antibiotics not in accordance to guidelines, a recent study has found.

What makes dentists prescribe antibiotics inappropriately?

09 Jun 2021

Nintedanib may spare lung in COVID-19

09 Jun 2021 by

The antifibrotic agent nintedanib appears to help minimize lung injury in patients with severe COVID-19 undergoing mechanical ventilation, with a recent study showing that treatment lowers the likelihood of acute respiratory failure, shortens ventilation time, and reduces the volume of high-attenuation areas on imaging.

Nintedanib may spare lung in COVID-19

09 Jun 2021

Tocilizumab administration for severe COVID-19: Timing matters

09 Jun 2021 by

Early administration (ie, pre-intubation/noninvasive ventilation) of the interleukin-6 receptor blocker tocilizumab in patients with severe COVID-19 led to more favourable outcomes compared with late administration (ie, post-intubation/noninvasive ventilation), according to data presented at ATS 2021.

Tocilizumab administration for severe COVID-19: Timing matters

09 Jun 2021

News & Updates

Filter by Specialty:

Specialty:

PAP-treated sleep apnoea tied to reduced COVID-19 risk

PAP-treated sleep apnoea tied to reduced COVID-19 risk

Regional variations in prevalence, hidden reservoir sustain malaria in Myanmar

Regional variations in prevalence, hidden reservoir sustain malaria in Myanmar

Therapeutic rivaroxaban for stable COVID-19: More risk than benefit

Therapeutic rivaroxaban for stable COVID-19: More risk than benefit

Antibody cocktail cuts hospitalization, death in COVID-19

Antibody cocktail cuts hospitalization, death in COVID-19

Skin reactions after Moderna, Pfizer COVID-19 vaccination not a cause for alarm

Skin reactions after Moderna, Pfizer COVID-19 vaccination not a cause for alarm

Chronic liver disease not a comorbidity of COVID-19

Chronic liver disease not a comorbidity of COVID-19

Wearing masks does not prevent COVID-19 infection

Wearing masks does not prevent COVID-19 infection

What makes dentists prescribe antibiotics inappropriately?

What makes dentists prescribe antibiotics inappropriately?

Nintedanib may spare lung in COVID-19

Nintedanib may spare lung in COVID-19

Tocilizumab administration for severe COVID-19: Timing matters

Tocilizumab administration for severe COVID-19: Timing matters